{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_doxorubicin",
          "type": "Drug",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_vincristine",
          "type": "Drug",
          "label": "Vincristine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_temozolomide",
          "type": "Drug",
          "label": "Temozolomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_etoposide",
          "type": "Drug",
          "label": "Etoposide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_bevacizumab",
          "type": "Drug",
          "label": "Bevacizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_methylprednisolone",
          "type": "Drug",
          "label": "Methylprednisolone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_olaparib",
          "type": "Drug",
          "label": "Olaparib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_lapatinib",
          "type": "Drug",
          "label": "Lapatinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_dasatinib",
          "type": "Drug",
          "label": "Dasatinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pegaspargase",
          "type": "Drug",
          "label": "Pegaspargase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_sulfonamides",
          "type": "Drug",
          "label": "Sulfonamides",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target",
          "type": "Target",
          "label": "Target",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway",
          "type": "Pathway",
          "label": "Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Familial tumour syndromes of the central and peripheral nervous system",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_doxorubicin",
          "type": "Drug",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Vincristine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_vincristine",
          "type": "Drug",
          "label": "Vincristine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Cylophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cylophosphamide",
          "type": "Drug",
          "label": "Cylophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Temozolomide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_temozolomide",
          "type": "Drug",
          "label": "Temozolomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Etoposide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_etoposide",
          "type": "Drug",
          "label": "Etoposide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Bevacizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_bevacizumab",
          "type": "Drug",
          "label": "Bevacizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Methylprednisolone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methylprednisolone",
          "type": "Drug",
          "label": "Methylprednisolone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Olaparib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_olaparib",
          "type": "Drug",
          "label": "Olaparib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Lapatinib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_lapatinib",
          "type": "Drug",
          "label": "Lapatinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Dasatinib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_dasatinib",
          "type": "Drug",
          "label": "Dasatinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Pegaspargase",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_pegaspargase",
          "type": "Drug",
          "label": "Pegaspargase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Sulfonamides",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_sulfonamides",
          "type": "Drug",
          "label": "Sulfonamides",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_doxorubicin",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_vincristine",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_temozolomide",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_etoposide",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_bevacizumab",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_methylprednisolone",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "使用于癌症相关症状的治疗"
        },
        {
          "source": "n_olaparib",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_lapatinib",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于特定类型癌症的靶向治疗"
        },
        {
          "source": "n_dasatinib",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于癌症特定途径"
        },
        {
          "source": "n_pegaspargase",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "癌症治疗中的应用"
        },
        {
          "source": "n_sulfonamides",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_target",
          "target": "n_pathway",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "靶点与通路的直接关联"
        },
        {
          "source": "n_pathway",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "病理机制与疾病的直接联系"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.54,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.0,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "潜在安全性风险未标识，但整体适应性良好"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H2",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.0,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "尚未发现重大安全性受限问题"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H3",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.0,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "应用适度，没有重大禁忌症"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H4",
          "score": 0.57,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "与特定患者群体的适应性相符合"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H5",
          "score": 0.56,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "适用性未有严重争议"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H6",
          "score": 0.6,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "无显在的禁忌问题"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H7",
          "score": 0.57,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.0,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "在使用情况下未发现重要安全问题"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H8",
          "score": 0.58,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.0,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "未声明重大禁忌"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H9",
          "score": 0.56,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "适应性尚可"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H10",
          "score": 0.57,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "风险可控"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H11",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "整体适应性良好"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H12",
          "score": 0.53,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.3,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.2
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的路径"
            ],
            "safety_risk": [
              "未发现显著安全性问题"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Familial tumor syndromes of the central and peripheral nervous system",
            "expectation": "若此类药物在该人群中展示安全性问题，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "各药物对家族性肿瘤综合症患者的安全性评估",
          "确认是否存在显著的适应症对比优势"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Familial tumor syndromes of the central and peripheral nervous system",
            "expectation": "若此类药物在该人群中展示安全性问题，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "各药物对家族性肿瘤综合症患者的安全性评估",
          "确认是否存在显著的适应症对比优势"
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Familial tumor syndromes of the central and peripheral nervous system",
            "expectation": "若此类药物在该人群中展示安全性问题，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "各药物对家族性肿瘤综合症患者的安全性评估",
          "确认是否存在显著的适应症对比优势"
        ]
      },
      {
        "hypothesis_id": "H4",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Familial tumor syndromes of the central and peripheral nervous system",
            "expectation": "若此类药物在该人群中展示安全性问题，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "各药物对家族性肿瘤综合症患者的安全性评估",
          "确认是否存在显著的适应症对比优势"
        ]
      },
      {
        "hypothesis_id": "H5",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Familial tumor syndromes of the central and peripheral nervous system",
            "expectation": "若此类药物在该人群中展示安全性问题，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "各药物对家族性肿瘤综合症患者的安全性评估",
          "确认是否存在显著的适应症对比优势"
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "所有现有候选的安全性评估缺失，需针对家族性肿瘤综合症探讨潜在的禁忌问题。",
      "n": 4
    }
  }
}